Rejuvion Bio

Rejuvion Bio is a pre-clinical stage biotechnology company focused on developing regenerative medicines to treat age-related diseases and tissue degeneration. The company's core technology centers on the longevity protein Klotho and its role in maintaining mitochondrial health and muscle regenerative capacity. By leveraging extracellular vesicles (EVs) to deliver rejuvenation factors, Rejuvion aims to restore the systemic environment of aging patients to a more youthful state. Their primary therapeutic focus is on sarcopenia and other musculoskeletal conditions associated with aging. The company was founded by leading researchers in regenerative medicine from the University of Pittsburgh and UCLA.